Clinical trial NCT00865514 - References

Healthy — Pharmacotoxicology of Trichloroethylene Metabolites

Citation(s)

•   Abbas RR, Seckel CS, Kidney JK, Fisher JW
  Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab Dispos. 1996 Dec;24(12):1340-6. Erratum in: Drug Metab Dispos 1997 Dec;25(12):1449.
•   Agbenyega T, Planche T, Bedu-Addo G, Ansong D, Owusu-Ofori A, Bhattaram VA, Nagaraja NV, Shroads AL, Henderson GN, Hutson AD, Derendorf H, Krishna S, Stacpoole PW
  Population kinetics, efficacy, and safety of dichloroacetate for lactic acidosis due to severe malaria in children. J Clin Pharmacol. 2003 Apr;43(4):386-96.
•   Akundi RS, Macho A, Muñoz E, Lieb K, Bringmann G, Clement HW, Hüll M, Fiebich BL
  1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH. J Neurochem. 2004 Oct;91(2):263-73.
•   Ammini CV, Fernandez-Canon J, Shroads AL, Cornett R, Cheung J, James MO, Henderson GN, Grompe M, Stacpoole PW
  Pharmacologic or genetic ablation of maleylacetoacetate isomerase increases levels of toxic tyrosine catabolites in rodents. Biochem Pharmacol. 2003 Nov 15;66(10):2029-38.
•   Anderson WB, Board PG, Anders MW
  Glutathione transferase zeta-catalyzed bioactivation of dichloroacetic acid: reaction of glyoxylate with amino acid nucleophiles. Chem Res Toxicol. 2004 May;17(5):650-62.
•   Anderson WB, Liebler DC, Board PG, Anders MW
  Mass spectral characterization of dichloroacetic acid-modified human glutathione transferase zeta. Chem Res Toxicol. 2002 Nov;15(11):1387-97.
•   Barak C, Reed MK, Maniscalco SP, Sherry AD, Malloy CR, Jessen ME
  Effects of dichloroacetate on mechanical recovery and oxidation of physiologic substrates after ischemia and reperfusion in the isolated heart. J Cardiovasc Pharmacol. 1998 Mar;31(3):336-44.
•   Barton CH, Bailey E
  Changes in immunoreactive malic enzyme in liver and brown adipose tissue during development of the rat. J Dev Physiol. 1987 Jun;9(3):215-24.
•   Blackburn AC, Coggan M, Tzeng HF, Lantum H, Polekhina G, Parker MW, Anders MW, Board PG
  GSTZ1d: a new allele of glutathione transferase zeta and maleylacetoacetate isomerase. Pharmacogenetics. 2001 Nov;11(8):671-8.
•   Blackburn AC, Tzeng HF, Anders MW, Board PG
  Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis. Pharmacogenetics. 2000 Feb;10(1):49-57.
•   Brown LP, Farrar DG, de Rooij CG
  Health risk assessment of environmental exposure to trichloroethylene. Regul Toxicol Pharmacol. 1990 Feb;11(1):24-41. Review.
•   Bruckner JV, Davis BD, Blancato JN
  Metabolism, toxicity, and carcinogenicity of trichloroethylene. Crit Rev Toxicol. 1989;20(1):31-50. Review.
•   Buben JA, O'Flaherty EJ
  Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: a dose-effect study. Toxicol Appl Pharmacol. 1985 Mar 30;78(1):105-22.
•   Bull RJ, Sanchez IM, Nelson MA, Larson JL, Lansing AJ
  Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology. 1990 Sep;63(3):341-59.
•   Cohen SL, Chait BT
  Mass spectrometry of whole proteins eluted from sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels. Anal Biochem. 1997 May 1;247(2):257-67.
•   Cornett R, James MO, Henderson GN, Cheung J, Shroads AL, Stacpoole PW
  Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: a potential unifying mechanism for its altered biotransformation and toxicity. Biochem Biophys Res Commun. 1999 Sep 7;262(3):752-6.
•   Daniel FB, DeAngelo AB, Stober JA, Olson GR, Page NP
  Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundam Appl Toxicol. 1992 Aug;19(2):159-68.
•   Davidson IW, Beliles RP
  Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab Rev. 1991;23(5-6):493-599. Review.
•   DeAngelo AB, Daniel FB, McMillan L, Wernsing P, Savage RE Jr
  Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol Appl Pharmacol. 1989 Nov;101(2):285-98.
•   DeAngelo AB, Daniel FB, Most BM, Olson GR
  The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology. 1996 Dec 18;114(3):207-21.
•   DeAngelo AB, Daniel FB, Stober JA, Olson GR
  The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam Appl Toxicol. 1991 Feb;16(2):337-47.
•   DeMarini DM, Perry E, Shelton ML
  Dichloroacetic acid and related compounds: induction of prophage in E. coli and mutagenicity and mutation spectra in Salmonella TA100. Mutagenesis. 1994 Sep;9(5):429-37.
•   Duncan GE, Perkins LA, Theriaque DW, Neiberger RE, Stacpoole PW
  Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism. J Clin Endocrinol Metab. 2004 Apr;89(4):1733-8.
•   Elcombe CR
  Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch Toxicol Suppl. 1985;8:6-17.
•   Everhart JL, Kurtz DT, McMillan JM
  Dichloroacetic acid induction of peroxisome proliferation in cultured hepatocytes. J Biochem Mol Toxicol. 1998;12(6):351-9.
•   Federal Register 40(203):49032-49045, 1975
  
•   Felitsyn NM, Henderson GN, James MO, Stacpoole PW
  Liquid chromatography-tandem mass spectrometry method for the simultaneous determination of delta-ALA, tyrosine and creatinine in biological fluids. Clin Chim Acta. 2004 Dec;350(1-2):219-30.
•   Fernández-Cañón JM, Baetscher MW, Finegold M, Burlingame T, Gibson KM, Grompe M
  Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism. Mol Cell Biol. 2002 Jul;22(13):4943-51.
•   Fernández-Cañón JM, Hejna J, Reifsteck C, Olson S, Grompe M
  Gene structure, chromosomal location, and expression pattern of maleylacetoacetate isomerase. Genomics. 1999 Jun 15;58(3):263-9.
•   Fischer W, Wirkner K, Weber M, Eberts C, Köles L, Reinhardt R, Franke H, Allgaier C, Gillen C, Illes P
  Characterization of P2X3, P2Y1 and P2Y4 receptors in cultured HEK293-hP2X3 cells and their inhibition by ethanol and trichloroethanol. J Neurochem. 2003 May;85(3):779-90.
•   Forkert PG, Lash LH, Nadeau V, Tardif R, Simmonds A
  Metabolism and toxicity of trichloroethylene in epididymis and testis. Toxicol Appl Pharmacol. 2002 Aug 1;182(3):244-54.
•   Fox AW, Yang X, Murli H, Lawlor TE, Cifone MA, Reno FE
  Absence of mutagenic effects of sodium dichloroacetate. Fundam Appl Toxicol. 1996 Jul;32(1):87-95.
•   Fujita H, Koizumi A, Yamamoto M, Kumai M, Sadamoto T, Ikeda M
  Inhibition of delta-aminolevulinate dehydratase in trichloroethylene-exposed rats, and the effects on heme regulation. Biochim Biophys Acta. 1984 Jul 16;800(1):1-10.
•   Fuscoe JC, Afshari AJ, George MH, DeAngelo AB, Tice RR, Salman T, Allen JW
  In vivo genotoxicity of dichloroacetic acid: evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay. Environ Mol Mutagen. 1996;27(1):1-9.
•   Gilbert KM, Whitlow AB, Pumford NR
  Environmental contaminant and disinfection by-product trichloroacetaldehyde stimulates T cells in vitro. Int Immunopharmacol. 2004 Jan;4(1):25-36.
•   Giller S, Le Curieux F, Erb F, Marzin D
  Comparative genotoxicity of halogenated acetic acids found in drinking water. Mutagenesis. 1997 Sep;12(5):321-8.
•   Gonzalez-Leon A, Schultz IR, Bull RJ
  Species differences in the toxicokinetics of dichloroacetate and trichloroacetate in F344 rats and B6C3F1 mice after prolonged administration in drinking water. Fundam Appl Toxicol Suppl 36, Abst. 168, p. 33, 1997.
•   Gonzalez-Leon A, Schultz IR, Xu G, Bull RJ
  Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water. Toxicol Appl Pharmacol. 1997 Oct;146(2):189-95. Erratum in: Toxicol Appl Pharmacol 1998 Jan;148(1):194.
•   Greenberg SB, Faerber EN, Aspinall CL
  High dose chloral hydrate sedation for children undergoing CT. J Comput Assist Tomogr. 1991 May-Jun;15(3):467-9.
•   Gribble GW
  Naturally occurring organohalogen compounds--a comprehensive survey. Fortschr Chem Org Naturst. 1996;68:1-423. Review.
•   Grompe M, Lindstedt S, al-Dhalimy M, Kennaway NG, Papaconstantinou J, Torres-Ramos CA, Ou CN, Finegold M
  Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nat Genet. 1995 Aug;10(4):453-60.
•   Grompe M, Overturf K, al-Dhalimy M, Finegold M
  Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report. J Inherit Metab Dis. 1998 Aug;21(5):518-31.
•   Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C
  Trichloroethylene and parkinsonism: a human and experimental observation. Eur J Neurol. 1999 Sep;6(5):609-11.
•   Guo X, Dixit V, Liu H, Shroads AL, Henderson GN, James MO, Stacpoole PW
  Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal. Drug Metab Dispos. 2006 Jan;34(1):36-42. Epub 2005 Sep 30.
•   Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R
  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999 Oct;17(10):994-9.
•   Harinath S, Sikdar SK
  Trichloroethanol enhances the activity of recombinant human TREK-1 and TRAAK channels. Neuropharmacology. 2004 Apr;46(5):750-60.
•   Harrington-Brock K, Doerr CL, Moore MM
  Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/- (-)3.7.2C mouse lymphoma cells. Mutat Res. 1998 Mar 30;413(3):265-76.
•   Hartley S, Franck LS, Lundergan F
  Maintenance sedation of agitated infants in the neonatal intensive care unit with chloral hydrate: new concerns. J Perinatol. 1989 Jun;9(2):162-4.
•   Henderson GN, Yan Z, James MO, Davydova N, Stacpoole PW
  Kinetics and metabolism of chloral hydrate in children: identification of dichloroacetate as a metabolite. Biochem Biophys Res Commun. 1997 Jun 27;235(3):695-8.
•   Henschler D, Romen W, Elsässer HM, Reichert D, Eder E, Radwan Z
  Carcinogenicity study of trichloroethylene by longterm inhalation in three animal species. Arch Toxicol. 1980 Feb;43(4):237-48.
•   Henschler D
  Metabolism and mutagenicity of halogenated olefins--a comparison of structure and activity. Environ Health Perspect. 1977 Dec;21:61-4.
•   Ho YS, Ma HY, Chang HY, Wei BL, Lee CC, Ho SY, Guo HR, Wu TP, Chang WH, Wang YJ
  Lipid peroxidation and cell death mechanisms in rats and human cells induced by chloral hydrate. Food Chem Toxicol. 2003 May;41(5):621-9.
•   Holme E, Lindstedt S
  Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). J Inherit Metab Dis. 1998 Aug;21(5):507-17. Review.
•   Hong JY, Pan JM, Gonzalez FJ, Gelboin HV, Yang CS
  The induction of a specific form of cytochrome P-450 (P-450j) by fasting. Biochem Biophys Res Commun. 1987 Feb 13;142(3):1077-83.
•   IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
  Chloral hydrate. World Health Organization, 2004, pp. 317-358.
•   Ikbal M, Tastekin A, Dogan H, Pirim I, Ors R
  The assessment of genotoxic effects in lymphocyte cultures of infants treated with chloral hydrate. Mutat Res. 2004 Dec 12;564(2):159-64.
•   James MO, Cornett R, Yan Z, Henderson GN, Stacpoole PW
  Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate biotransformation in hepatic cytosol from humans and rats, is reduced in dichloroacetate-treated rats. Drug Metab Dispos. 1997 Nov;25(11):1223-7.
•   Jia M, Wu WW, Yost RA, Chadik PA, Stacpoole PW, Henderson GN
  Simultaneous determination of trace levels of nine haloacetic acids in biological samples as their pentafluorobenzyl derivatives by gas chromatography/tandem mass spectrometry in electron capture negative ion chemical ionization mode. Anal Chem. 2003 Aug 15;75(16):4065-80.
•   Jochemsen R, Breimer DD
  Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles. Curr Med Res Opin. 1984;8 Suppl 4:60-79.
•   Jolley RL
  Basic issues in water chlorination: a chemical perspective. In, Water chlorination: chemistry, environmental impact and health effects. Lewis Publ, Inc. Chelsea, MI 5:19-38, 1985.
•   Josephson J
  ES Views: Implementing Superfund. Environ Sci Technol. 1986 Jan 1;20(1):23-8. doi: 10.1021/es00143a601.
•   Kato-Weinstein J, Lingohr MK, Orner GA, Thrall BD, Bull RJ
  Effects of dichloroacetate on glycogen metabolism in B6C3F1 mice. Toxicology. 1998 Sep 15;130(2-3):141-54.
•   Kaufmann P, Engelstad K, Wei Y, Jhung S, Sano MC, Shungu DC, Millar WS, Hong X, Gooch CL, Mao X, Pascual JM, Hirano M, Stacpoole PW, DiMauro S, De Vivo DC
  Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology. 2006 Feb 14;66(3):324-30.
•   Kinter M, Sherman NE
  Peptide Sequencng andIdentifcation Using Tandem Mass Specrometry. John Wiley and Sons, Inc., pp. 147-165, 2000.
•   Krsek P, Sebronová V, Procházka T, Maulisová A, Komárek V
  Successful treatment of Ohtahara syndrome with chloral hydrate. Pediatr Neurol. 2002 Nov;27(5):388-91.
•   Kuhn JP
  CT of the body in children. Pediatr Ann. 1986 May;15(5):367, 371-3, 376-82.
•   LARC Monogr Eval Carcinog Risks Hum 11:263-276,1979
  
•   Larson JL, Bull RJ
  Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol Appl Pharmacol. 1992 Aug;115(2):278-85.
•   Leavitt SA, DeAngelo AB, George MH, Ross JA
  Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver. Carcinogenesis. 1997 Nov;18(11):2101-6.
•   Liebreich O
  Das Chloral hydrat, ein neues Hypnoticum und Anaestheticum, 3rd ed. Berlin: Otto Mullers Verlag, 1869.
•   Lingohr MK, Thrall BD, Bull RJ
  Effects of dichloroacetate (DCA) on serum insulin levels and insulin-controlled signaling proteins in livers of male B6C3F1 mice. Toxicol Sci. 2001 Jan;59(1):178-84.
•   LoPachin RM, Jones RC, Patterson TA, Slikker W Jr, Barber DS
  Application of proteomics to the study of molecular mechanisms in neurotoxicology. Neurotoxicology. 2003 Dec;24(6):761-75. Review.
•   Maloney EK, Waxman DJ
  trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol Appl Pharmacol. 1999 Dec 1;161(2):209-18.
•   Malviya S, Voepel-Lewis T, Tait AR, Reynolds PI, Gujar SK, Gebarski SS, Petter Eldevik O
  Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatr Anaesth. 2004 Jul;14(7):589-95.
•   Mariash CN, Schwartz HL
  Effect of dichloroacetic acid on rat hepatic messenger RNA activity profiles. Metabolism. 1986 May;35(5):452-6.
•   MARSHALL EK Jr, OWENS AH Jr
  Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol. Bull Johns Hopkins Hosp. 1954 Jul;95(1):1-18.
•   McHugh Law J, Lopez L, DeAngelo AB
  Hepatotoxicity of the drinking water disinfection by-product, dichloroacetic acid, in the medaka small fish model. Toxicol Lett. 1998 Jan 16;94(1):19-27.
•   Miller JW, Uden PC
  Characterization of nonvolatile aqueous chlorination products of humic substances. Environ Sci Technol. 1983 Mar 1;17(3):150-7. doi: 10.1021/es00109a006.
•   Miller RR, Greenblatt DJ
  Clinical effects of chloral hydrate in hospitalized medical patients. J Clin Pharmacol. 1979 Oct;19(10):669-74.
•   Mortazavi B, Chanton JP
  A rapid and precise technique for measuring delta(13)C-CO(2) and delta(18)O-CO(2) ratios at ambient CO(2) concentrations for biological applications and the influence of container type and storage time on the sample isotope ratios. Rapid Commun Mass Spectrom. 2002;16(14):1398-403.
•   Mughal FH
  Chlorination of drinking water and cancer: a review. J Environ Pathol Toxicol Oncol. 1992 Sep-Oct;11(5-6):287-92. Review.
•   Nathan JE
  Management of the refractory young child with chloral hydrate: dosage selection. ASDC J Dent Child. 1987 Mar-Apr;54(2):93-100.
•   National Toxicology Program
  Toxicology Carcinogenesis Studies of Trichloroethylene (Without Epichlorohydon)(CAS No. 7.9-011-6) in F3dd/N Rats B6C3F1 Mice (Gavage Studies). Research Triangle Park, NC: US Department of Health Human Services; Technical report series No. 243; NIH Publication 9:0-1779, 1990.
•   Neiberger RE, George JC, Perkins LA, Theriaque DW, Hutson AD, Stacpoole PW
  Renal manifestations of congenital lactic acidosis. Am J Kidney Dis. 2002 Jan;39(1):12-23.
•   Nelson MA, Bull RJ
  Induction of strand breaks in DNA by trichloroethylene and metabolites in rat and mouse liver in vivo. Toxicol Appl Pharmacol. 1988 Jun 15;94(1):45-54.
•   Nguyen MH, Keeffe EB
  Chronic hepatitis B and hepatitis C in Asian Americans. Rev Gastroenterol Disord. 2003 Summer;3(3):125-34. Review.
•   NTP Technical Report
  Toxicology and carcinogenesis study of chloral hydrate. NIH Publication No. 03-4437, 2002.
•   Page N
  Assessment of trichloroethylene as an occupational carcinogen. In: Davis W, Rosenfeld C, eds. Carcinogenic risks: strategies for intervention INSERM Symposia series Vol. 74. Lyon, France: International Agency for Reserach on Cancerl; IARC Scientific Publications E No. 25, 1979.
•   Pereira MA, Li K, Kramer PM
  Promotion by mixtures of dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. Cancer Lett. 1997 May 1;115(1):15-23.
•   Pereira MA, Phelps JB
  Promotion by dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. Cancer Lett. 1996 Apr 19;102(1-2):133-41.
•   Proteome Research: mass spectrometry
  Peter James. Springer, pp. 5-9 2001.
•   Rapson WH, Nazar MA, Butsky VV
  Mutagenicity produced by aqueous chlorination of organic compounds. Bull Environ Contam Toxicol. 1980 Apr;24(4):590-6.
•   Reif JS, Burch JB, Nuckols JR, Metzger L, Ellington D, Anger WK
  Neurobehavioral effects of exposure to trichloroethylene through a municipal water supply. Environ Res. 2003 Nov;93(3):248-58.
•   Reimche LD, Sankaran K, Hindmarsh KW, Kasian GF, Gorecki DK, Tan L
  Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations. Dev Pharmacol Ther. 1989;12(2):57-64.
•   Righetti PG, Castagna A, Antonucci F, Piubelli C, Cecconi D, Campostrini N, Zanusso G, Monaco S
  The proteome: anno Domini 2002. Clin Chem Lab Med. 2003 Apr;41(4):425-38. Review.
•   Ritz MA, Fraser R, Edwards N, Di Matteo AC, Chapman M, Butler R, Cmielewski P, Tournadre JP, Davidson G, Dent J
  Delayed gastric emptying in ventilated critically ill patients: measurement by 13 C-octanoic acid breath test. Crit Care Med. 2001 Sep;29(9):1744-9.
•   Ronaghi M
  Pyrosequencing sheds light on DNA sequencing. Genome Res. 2001 Jan;11(1):3-11. Review.
•   Sabeti J, Gerhardt GA, Zahniser NR
  Chloral hydrate and ethanol, but not urethane, alter the clearance of exogenous dopamine recorded by chronoamperometry in striatum of unrestrained rats. Neurosci Lett. 2003 May 29;343(1):9-12.
•   Salmon AG, Jackson RJ, Smith MT
  Chloral hydrate: cancer risk assessment of a drug previously presumed safe. The Toxicologist 11:350, 1991.
•   Sanchez IM, Bull RJ
  Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate. Toxicology. 1990 Oct;64(1):33-46.
•   Shroads AL, Henderson GN, Cheung J, James MO, Stacpoole PW
  Unified gas chromatographic-mass spectrometric method for quantitating tyrosine metabolites in urine and plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Sep 5;808(2):153-61.
•   Snyder RD, Pullman J, Carter JH, Carter HW, DeAngelo AB
  In vivo administration of dichloroacetic acid suppresses spontaneous apoptosis in murine hepatocytes. Cancer Res. 1995 Sep 1;55(17):3702-5.
•   Stacpoole PW, Barnes CL, Hurbanis MD, Cannon SL, Kerr DS
  Treatment of congenital lactic acidosis with dichloroacetate. Arch Dis Child. 1997 Dec;77(6):535-41.
•   Stacpoole PW, Harman EM, Curry SH, Baumgartner TG, Misbin RI
  Treatment of lactic acidosis with dichloroacetate. N Engl J Med. 1983 Aug 18;309(7):390-6.
•   Stacpoole PW, Harwood HJ Jr, Cameron DF, Curry SH, Samuelson DA, Cornwell PE, Sauberlich HE
  Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats. Fundam Appl Toxicol. 1990 Feb;14(2):327-37.
•   Stacpoole PW, Henderson GN, Yan Z, Cornett R, James MO
  Pharmacokinetics, metabolism and toxicology of dichloroacetate. Drug Metab Rev. 1998 Aug;30(3):499-539. Review.
•   Stacpoole PW, Kerr DS, Barnes C, Bunch ST, Carney PR, Fennell EM, Felitsyn NM, Gilmore RL, Greer M, Henderson GN, Hutson AD, Neiberger RE, O'Brien RG, Perkins LA, Quisling RG, Shroads AL, Shuster JJ, Silverstein JH, Theriaque DW, Valenstein E
  Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics. 2006 May;117(5):1519-31.
•   Stacpoole PW, Moore GW, Kornhauser DM
  Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia. N Engl J Med. 1978 Mar 9;298(10):526-30.
•   Stacpoole PW, Moore GW, Kornhauser DM
  Toxicity of chronic dichloroacetate. N Engl J Med. 1979 Feb 15;300(7):372.
•   Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, Duncan CA, Harman EM, Henderson GN, Jenkinson S, et al
  A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med. 1992 Nov 26;327(22):1564-9.
•   Stacpoole PW
  The pharmacology of dichloroacetate. Metabolism. 1989 Nov;38(11):1124-44. Review.
•   Steinberg AD, DeSesso JM
  Have animal data been used inappropriately to estimate risks to humans from environmental trichloroethylene? Regul Toxicol Pharmacol. 1993 Oct;18(2):137-53. Review.
•   Templin MV, Parker JC, Bull RJ
  Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol Appl Pharmacol. 1993 Nov;123(1):1-8. Erratum in: Toxicol Appl Pharmacol 1995 Jul;133(1):177.
•   Thai SF, Allen JW, DeAngelo AB, George MH, Fuscoe JC
  Detection of early gene expression changes by differential display in the livers of mice exposed to dichloroacetic acid. Carcinogenesis. 2001 Aug;22(8):1317-22.
•   Tong Z, Board PG, Anders MW
  Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem J. 1998 Apr 15;331 ( Pt 2):371-4.
•   Toxicological review of dichloroacetic acid (CAS No
  79-43-6). U.S. Environ. Protection Agency. Washington, DC, August, 2003.
•   Tzeng HF, Blackburn AC, Board PG, Anders MW
  Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate. Chem Res Toxicol. 2000 Apr;13(4):231-6.
•   Uden PCC, Miller JW
  Chlorinated acids and chloral in drinking water. J Amer Water Works Assoc 75:524-527, 1983.
•   Van Duuren BL, Banerjee S
  Covalent interaction of metabolites of the carcinogen trichloroethylene in rat hepatic microsomes. Cancer Res. 1976 Jul;36(7 PT 1):2419-22.
•   Waskell L
  A study of the mutagenicity of anesthetics and their metabolites. Mutat Res. 1978 May;57(2):141-53.
•   Waxman DJ
  P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys. 1999 Sep 1;369(1):11-23. Review.
•   Weir MR, Segapeli JH, Tremper LJ
  Sedation for pediatric procedures. Mil Med. 1986 Mar;151(3):181-4.
•   Westrick JJ, Mello JW, Thomas RF
  The groundwater supply survey. J Am Water Works 76:52, 1984.
•   Xu H, Tanphaichitr N, Forkert PG, Anupriwan A, Weerachatyanukul W, Vincent R, Leader A, Wade MG
  Exposure to trichloroethylene and its metabolites causes impairment of sperm fertilizing ability in mice. Toxicol Sci. 2004 Dec;82(2):590-7. Epub 2004 Sep 16.
•   Yan Z, Henderson GN, James MO, Stacpoole PW
  Determination of dichloroacetate and its metabolites in human plasma by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 1997 Dec 5;703(1-2):75-84.
•   Yang HM, Houser WH, Davis ME
  Dichloroacetic acid treatment increases hepatic CYP2E1 in male and female rats. Toxicol Appl Pharmacol. 1996 Dec;141(2):382-8.
•   Yoo JS, Park HS, Ning SM, Lee MJ, Yang CS
  Effects of thiamine deficiency on hepatic cytochromes P450 and drug-metabolizing enzyme activities. Biochem Pharmacol. 1990 Feb 1;39(3):519-25.
•   Zhou YC, Waxman DJ
  Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids. Environ Health Perspect. 1998 Aug;106 Suppl 4:983-8.

Pharmacotoxicology of Trichloroethylene Metabolites: Short-term Effect of DCA on in Vivo Tyrosine Catabolism and MAAI Expression

Details for clinical trial NCT00865514